Free Trial
→ Your $29.97 book is free today (From Profits Run) (Ad)tc pixel Free SYK Stock Alerts

Stryker (SYK) Financials

Stryker logo
$302.14 +7.69 (+2.61%)
Closing price 05/13/2026 03:59 PM Eastern
Extended Trading
$301.42 -0.73 (-0.24%)
As of 08:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Stryker

Annual Income Statements for Stryker

This table shows Stryker's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 1,439 1,647 1,020 3,553 2,083 1,599 1,994 2,358 3,165 2,993 3,246
Consolidated Net Income / (Loss)		 1,439 1,647 1,020 3,553 2,083 1,599 1,994 2,358 3,165 2,993 3,246
Net Income / (Loss) Continuing Operations		 1,439 1,647 1,020 3,553 2,083 1,599 1,994 2,358 3,165 2,993 3,246
Total Pre-Tax Income 		1,735 1,921 2,063 2,356 2,562 1,954 2,281 2,683 3,673 3,492 4,514
Total Operating Income		 1,861 2,175 2,297 2,537 2,713 2,223 2,584 2,841 3,888 3,689 4,889
Total Gross Profit		 6,602 7,504 8,180 8,938 9,696 9,057 10,968 11,578 13,058 14,440 16,065
Total Revenue		 9,946 11,325 12,444 13,601 14,884 14,351 17,108 18,449 20,498 22,595 25,116
Operating Revenue		 9,946 11,325 12,444 13,601 14,884 14,351 17,108 18,449 20,498 22,595 25,116
Total Cost of Revenue		 3,344 3,821 4,264 4,663 5,188 5,294 6,140 6,871 7,440 8,155 9,051
Operating Cost of Revenue		 3,344 3,821 4,264 4,663 5,188 5,294 6,140 6,871 7,440 8,155 9,051
Total Operating Expenses		 4,741 5,329 5,883 6,401 6,983 6,834 8,384 8,737 9,170 10,751 11,176
Selling, General & Admin Expense		 3,610 4,137 4,552 5,099 5,356 5,361 6,427 6,386 7,111 7,685 8,651
Research & Development Expense		 625 715 787 862 971 984 1,235 1,454 1,388 1,466 1,623
Amortization Expense		 210 319 371 417 464 472 619 627 635 623 732
Impairment Charge		 - - - - - 0.00 0.00 270 36 977 170
Total Other Income / (Expense), net		 -126 -254 -234 -181 -151 -269 -303 -158 -215 -197 -375
Interest Expense		 - - - - - - - - 363 409 607
Other Income / (Expense), net		 -126 -254 -234 -181 -151 -269 -303 -158 148 212 232
Income Tax Expense		 296 274 1,043 -1,197 479 355 287 325 508 499 1,268
Basic Earnings per Share		 $3.82 $4.40 $2.73 $9.50 $5.57 $4.26 $5.29 $6.23 $8.34 $7.86 $8.49
Weighted Average Basic Shares Outstanding		 376.60M 374.10M 374M 374.10M 374M 375.50M 377M 378.20M 379.60M 381M 382.20M
Diluted Earnings per Share		 $3.78 $4.35 $2.68 $9.34 $5.48 $4.20 $5.21 $6.17 $8.25 $7.76 $8.40
Weighted Average Diluted Shares Outstanding		 380.90M 378.50M 380.10M 380.30M 379.90M 380.30M 382.30M 382.20M 383.70M 385.60M 386.50M
Weighted Average Basic & Diluted Shares Outstanding		 376.70M 374.30M 373.60M 374M 374.58M 376.20M 377.54M 378.83M 380.26M 381.58M 382.69M
Cash Dividends to Common per Share		 $1.42 $1.57 $1.75 $1.93 $2.14 $2.36 $2.59 $2.84 $3.05 $3.24 $3.40

Quarterly Income Statements for Stryker

This table shows Stryker's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 692 1,143 788 825 834 546 654 884 859 849 745
Consolidated Net Income / (Loss)		 692 1,143 788 825 834 546 654 884 859 849 745
Net Income / (Loss) Continuing Operations		 692 1,143 788 825 834 546 654 884 859 849 745
Total Pre-Tax Income 		869 1,226 923 998 1,043 528 764 1,016 1,029 1,705 850
Total Operating Income		 931 1,257 972 1,051 1,085 581 837 1,113 1,135 1,804 936
Total Gross Profit		 3,158 3,703 3,333 3,416 3,517 4,174 3,744 3,841 3,852 4,628 3,810
Total Revenue		 4,909 5,815 5,243 5,422 5,494 6,436 5,866 6,022 6,057 7,171 6,020
Operating Revenue		 4,909 5,815 5,243 5,422 5,494 6,436 5,866 6,022 6,057 7,171 6,020
Total Cost of Revenue		 1,751 2,112 1,910 2,006 1,977 2,262 2,122 2,181 2,205 2,543 2,210
Operating Cost of Revenue		 1,751 2,112 1,910 2,006 1,977 2,262 2,122 2,181 2,205 2,543 2,210
Total Operating Expenses		 2,227 2,446 2,361 2,365 2,432 3,593 2,907 2,728 2,717 2,824 2,874
Selling, General & Admin Expense		 1,710 1,911 1,837 1,831 1,894 2,102 2,300 2,079 2,045 2,227 2,281
Research & Development Expense		 353 350 368 363 377 358 405 407 410 401 413
Amortization Expense		 164 149 153 155 159 156 167 187 189 189 180
Impairment Charge		 - - 3.00 16 2.00 - 35 55 73 7.00 0.00
Total Other Income / (Expense), net		 -62 -31 -49 -53 -42 -53 -73 -97 -106 -99 -86
Interest Expense		 - - - - - - 137 - - - 148
Other Income / (Expense), net		 -62 -31 -49 -53 -42 -53 64 -97 -106 508 62
Income Tax Expense		 177 83 135 173 209 -18 110 132 170 856 105
Basic Earnings per Share		 $1.82 $3.01 $2.07 $2.17 $2.18 $1.44 $1.71 $2.32 $2.25 $2.21 $1.95
Weighted Average Basic Shares Outstanding		 379.80M 379.60M 380.40M 381M 381.10M 381M 381.70M 382.20M 382.40M 382.20M 382.90M
Diluted Earnings per Share		 $1.80 $2.98 $2.05 $2.14 $2.16 $1.41 $1.69 $2.29 $2.22 $2.20 $1.93
Weighted Average Diluted Shares Outstanding		 384M 383.70M 385.10M 385.40M 385.60M 385.60M 386.40M 386.40M 386.70M 386.50M 386.50M
Weighted Average Basic & Diluted Shares Outstanding		 379.89M 380.26M 380.95M 381.08M 381.22M 381.58M 382.16M 382.31M 382.42M 382.69M 383.36M
Cash Dividends to Common per Share		 $0.75 - $0.80 $0.80 $0.80 - $0.84 $0.84 $0.84 - $0.88

Annual Cash Flow Statements for Stryker

This table details how cash moves in and out of Stryker's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 1,584 -63 -774 1,082 721 -1,394 1.00 -1,100 1,127 681 359
Net Cash From Operating Activities		 981 1,915 1,559 2,610 2,191 3,277 3,263 2,624 3,711 4,242 5,044
Net Cash From Continuing Operating Activities		 981 1,915 1,559 2,610 2,191 3,277 3,263 2,624 3,711 4,242 5,044
Net Income / (Loss) Continuing Operations		 1,439 1,647 1,020 3,553 2,083 1,599 1,994 2,358 3,165 2,993 3,246
Consolidated Net Income / (Loss)		 1,439 1,647 1,020 3,553 2,083 1,599 1,994 2,358 3,165 2,993 3,246
Depreciation Expense		 187 227 271 306 314 340 371 371 393 427 461
Amortization Expense		 210 319 371 417 464 472 619 627 635 623 732
Non-Cash Adjustments To Reconcile Net Income		 -764 101 -218 82 225 405 583 450 241 1,252 586
Changes in Operating Assets and Liabilities, net		 -91 -379 115 -1,748 -895 461 -304 -1,182 -723 -1,053 19
Net Cash From Investing Activities		 1,956 -4,191 -1,613 -2,857 -1,455 -4,701 -859 -2,924 -962 -3,000 -4,866
Net Cash From Continuing Investing Activities		 1,956 -4,191 -1,613 -2,857 -1,455 -4,701 -859 -2,924 -962 -3,000 -4,866
Purchase of Property, Plant & Equipment		 -270 -490 -598 -572 -649 -487 -525 -588 -575 -755 -761
Acquisitions		 -153 -4,332 -831 -2,451 -802 -4,222 -339 -2,563 -390 -1,628 -4,960
Divestitures		 - - - - - - - - 0.00 0.00 165
Sale and/or Maturity of Investments		 4,094 785 87 394 69 61 55 240 0.00 -750 750
Other Investing Activities, net		 0.00 -3.00 -1.00 -2.00 1.00 1.00 -1.00 39 3.00 133 -60
Net Cash From Financing Activities		 -1,223 2,258 -794 1,329 3.00 -11 -2,365 -749 -1,594 -525 113
Net Cash From Continuing Financing Activities		 -1,223 2,258 -794 1,329 3.00 -11 -2,365 -749 -1,594 -525 113
Repayment of Debt		 -2,266 -756 -233 -670 -1,349 -2,330 -1,306 -1,076 -1,541 -2,122 -1,433
Payment of Dividends		 -521 -568 -735 -717 -778 -863 -950 -1,051 -1,139 -1,219 -1,284
Issuance of Debt		 2,320 3,662 499 3,136 2,573 3,292 5.00 1,500 1,241 3,011 2,979
Other Financing Activities, net		 -56 -67 -95 -120 -136 -110 -114 -122 -155 -195 -149
Effect of Exchange Rate Changes		 -130 -45 74 - -18 41 -38 -51 -28 -36 68
Cash Interest Paid		 101 180 231 248 286 304 325 324 356 396 582
Cash Income Taxes Paid		 497 510 312 539 457 323 622 505 693 989 1,002

Quarterly Cash Flow Statements for Stryker

This table details how cash moves in and out of Stryker's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 459 1,111 -641 -456 1,976 -198 -1,332 55 881 755 -1,133
Net Cash From Operating Activities		 1,050 1,528 204 633 1,474 1,931 250 1,111 1,540 2,143 581
Net Cash From Continuing Operating Activities		 1,050 1,528 204 633 1,474 1,931 250 1,111 1,540 2,143 581
Net Income / (Loss) Continuing Operations		 692 1,143 788 825 834 546 654 884 859 849 745
Consolidated Net Income / (Loss)		 692 1,143 788 825 834 546 654 884 859 849 745
Depreciation Expense		 98 101 107 103 109 108 105 109 120 127 120
Amortization Expense		 164 149 153 155 159 156 167 187 189 189 180
Non-Cash Adjustments To Reconcile Net Income		 61 64 90 71 82 1,009 153 169 196 68 87
Changes in Operating Assets and Liabilities, net		 35 71 -934 -521 290 112 -829 -238 176 910 -551
Net Cash From Investing Activities		 -145 -152 -408 -117 -2,172 -303 -4,136 -104 -321 -305 -185
Net Cash From Continuing Investing Activities		 -145 -152 -408 -117 -2,172 -303 -4,136 -104 -321 -305 -185
Purchase of Property, Plant & Equipment		 -148 -145 -167 -152 -170 -266 -123 -183 -187 -268 -166
Acquisitions		 - - -246 -88 -1,264 -30 -4,749 -65 -136 -10 -22
Purchase of Investments		 -6.00 -11 -18 -14 -759 -17 -11 -16 -5.00 - -5.00
Sale and/or Maturity of Investments		 7.00 5.00 23 107 9.00 9.00 767 15 8.00 -40 7.00
Other Investing Activities, net		 2.00 -1.00 0.00 30 12 1.00 -20 -20 -1.00 -19 1.00
Net Cash From Financing Activities		 -422 -286 -418 -966 2,653 -1,794 2,534 -989 -339 -1,093 -1,510
Net Cash From Continuing Financing Activities		 -422 -286 -418 -966 2,653 -1,794 2,534 -989 -339 -1,093 -1,510
Repayment of Debt		 -671 -668 -1.00 -648 -34 -1,440 -24 -654 - -755 -1,034
Payment of Dividends		 -285 -285 -304 -305 -305 -305 -320 -321 -322 -321 -337
Issuance of Debt		 544 701 0.00 1.00 3,011 - 2,979 - - - 0.00
Other Financing Activities, net		 -10 -34 -113 -14 -19 -49 -101 -14 -17 -17 -139
Effect of Exchange Rate Changes		 - - -19 - - -32 20 37 1.00 10 -19

Annual Balance Sheets for Stryker

This table presents Stryker's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 16,223 20,435 22,197 27,229 30,167 34,330 34,631 36,884 39,912 42,971 47,844
Total Current Assets		 7,943 7,861 7,993 9,733 11,058 9,707 10,017 10,275 12,518 14,847 14,755
Cash & Equivalents		 3,379 3,316 2,542 3,616 4,337 2,943 2,944 1,844 2,971 3,652 4,011
Short-Term Investments		 700 68 251 83 88 81 75 84 82 841 89
Accounts Receivable		 1,662 1,967 2,198 2,332 2,893 2,701 3,022 3,565 3,765 3,987 4,039
Inventories, net		 1,639 2,030 2,465 2,955 2,980 3,494 3,314 3,995 4,843 4,774 5,310
Prepaid Expenses		 563 480 537 747 760 488 662 787 857 1,593 1,306
Plant, Property, & Equipment, net		 1,199 1,569 1,975 2,291 2,567 2,752 2,833 2,970 3,215 3,448 3,876
Plant, Property & Equipment, gross		 2,730 3,161 3,800 4,277 4,714 5,182 5,498 5,805 6,344 6,683 7,537
Accumulated Depreciation		 1,531 1,592 1,825 1,986 2,147 2,430 2,665 2,835 3,129 3,235 3,661
Total Noncurrent Assets		 7,081 11,005 12,229 15,205 16,542 21,871 21,781 23,639 24,179 24,676 29,213
Goodwill		 4,136 6,356 7,168 8,563 9,069 12,778 12,918 14,880 15,243 15,855 19,291
Intangible Assets		 1,794 3,508 3,477 4,163 4,227 5,554 4,840 4,885 4,593 4,395 5,681
Noncurrent Deferred & Refundable Income Taxes		 - - 283 1,678 1,575 1,530 1,760 1,410 1,670 1,742 1,098
Other Noncurrent Operating Assets		 1,151 1,141 1,301 801 1,671 2,009 2,263 2,464 2,673 2,684 3,143
Total Liabilities & Shareholders' Equity		 16,223 20,435 22,197 27,229 30,167 34,330 34,631 36,884 39,912 42,971 47,844
Total Liabilities		 7,712 10,885 12,217 15,499 17,360 21,246 19,754 20,268 21,319 22,337 25,424
Total Current Liabilities		 3,502 3,148 3,485 4,807 4,400 5,041 4,549 6,303 7,921 7,616 7,794
Short-Term Debt		 768 228 632 1,373 859 761 7.00 1,191 2,094 1,409 1,000
Accounts Payable		 410 437 487 646 675 810 1,129 1,413 1,517 1,679 1,799
Dividends Payable		 142 159 178 192 213 237 263 284 304 320 337
Current Deferred & Payable Income Tax Liabilities		 141 40 143 158 171 207 192 292 391 539 418
Current Employee Benefit Liabilities		 637 767 838 917 955 925 1,092 1,149 1,478 1,403 1,595
Other Current Liabilities		 710 923 1,207 1,521 1,196 1,586 1,465 1,744 2,137 2,266 2,645
Total Noncurrent Liabilities		 4,210 7,737 8,732 10,692 12,960 16,205 15,205 13,965 13,398 14,721 17,630
Long-Term Debt		 3,230 6,686 6,590 8,486 10,231 13,230 12,472 11,857 10,901 12,188 14,859
Noncurrent Deferred Revenue		 - 287 1,261 1,228 1,068 990 913 641 567 349 402
Other Noncurrent Operating Liabilities		 980 764 881 978 1,661 1,985 1,820 1,467 1,930 2,184 2,369
Total Equity & Noncontrolling Interests		 8,511 9,550 9,980 11,730 12,807 13,084 14,877 16,616 18,593 20,634 22,420
Total Preferred & Common Equity		 8,511 9,550 9,966 11,730 12,807 13,084 14,877 16,616 18,593 20,634 22,420
Total Common Equity		 8,511 9,550 9,966 11,730 12,807 13,084 14,877 16,616 18,593 20,634 22,420
Common Stock		 1,358 1,469 1,533 1,596 1,665 1,779 1,928 2,072 2,238 2,399 2,635
Retained Earnings		 7,792 8,842 8,986 10,765 11,748 12,462 13,480 14,765 16,771 18,528 20,472
Accumulated Other Comprehensive Income / (Loss)		 -639 -761 -553 -631 -606 -1,157 -531 -221 -416 -293 -687

Quarterly Balance Sheets for Stryker

This table presents Stryker's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 37,409 38,042 39,912 39,402 39,130 43,833 42,971 46,006 46,331 47,057 46,291
Total Current Assets		 10,151 11,045 12,518 11,892 11,645 14,673 14,847 13,022 13,003 13,711 13,338
Cash & Equivalents		 1,401 1,860 2,971 2,330 1,874 3,850 3,652 2,320 2,375 3,256 2,878
Short-Term Investments		 77 76 82 77 83 834 841 89 89 87 87
Accounts Receivable		 3,261 3,276 3,765 3,473 3,622 3,736 3,987 3,961 3,918 3,643 3,571
Inventories, net		 4,593 4,883 4,843 5,026 5,044 5,292 4,774 5,105 5,289 5,370 5,419
Prepaid Expenses		 819 950 857 986 1,022 961 1,593 1,547 1,332 1,355 1,383
Plant, Property, & Equipment, net		 3,082 3,106 3,215 3,260 3,318 3,429 3,448 3,536 3,702 3,734 3,887
Plant, Property & Equipment, gross		 6,087 6,155 6,344 6,458 6,622 6,889 6,683 6,910 7,272 7,405 7,630
Accumulated Depreciation		 3,005 3,049 3,129 3,198 3,304 3,460 3,235 3,374 3,570 3,671 3,743
Total Noncurrent Assets		 24,176 23,891 24,179 24,250 24,167 25,731 24,676 29,448 29,626 29,612 29,066
Goodwill		 15,172 15,138 15,243 15,351 15,408 16,396 15,855 19,089 19,183 19,256 19,188
Intangible Assets		 4,917 4,731 4,593 4,509 4,363 4,940 4,395 6,132 5,962 5,845 5,516
Noncurrent Deferred & Refundable Income Taxes		 1,439 1,406 1,670 1,641 1,606 1,562 1,742 1,411 1,375 1,374 1,193
Other Noncurrent Operating Assets		 2,648 2,616 2,673 2,749 2,790 2,833 2,684 2,816 3,106 3,137 3,169
Total Liabilities & Shareholders' Equity		 37,409 38,042 39,912 39,402 39,130 43,833 42,971 46,006 46,331 47,057 46,291
Total Liabilities		 20,048 20,137 21,319 20,230 19,368 23,684 22,337 25,076 25,140 25,272 23,312
Total Current Liabilities		 6,584 7,458 7,921 6,955 6,926 7,669 7,616 7,929 7,288 7,414 6,315
Short-Term Debt		 1,798 2,308 2,094 2,058 2,095 2,159 1,409 2,398 1,751 1,750 499
Accounts Payable		 1,326 1,296 1,517 1,246 1,304 1,337 1,679 1,464 1,442 1,498 1,592
Dividends Payable		 284 285 304 305 305 305 320 320 321 321 337
Current Deferred & Payable Income Tax Liabilities		 298 407 391 444 334 394 539 599 91 118 476
Current Employee Benefit Liabilities		 929 1,223 1,478 778 887 1,250 1,403 919 1,075 1,306 885
Other Current Liabilities		 1,729 1,715 2,137 2,124 2,001 2,224 2,266 2,229 2,608 2,421 2,526
Total Noncurrent Liabilities		 13,464 12,679 13,398 13,275 12,442 16,015 14,721 17,147 17,852 17,858 16,997
Long-Term Debt		 11,149 10,382 10,901 10,807 10,127 13,325 12,188 14,383 14,829 14,845 14,224
Noncurrent Deferred Revenue		 469 465 567 565 350 368 349 372 395 400 403
Other Noncurrent Operating Liabilities		 1,846 1,832 1,930 1,903 1,965 2,322 2,184 2,392 2,628 2,613 2,370
Total Equity & Noncontrolling Interests		 17,361 17,905 18,593 19,172 19,762 20,149 20,634 20,930 21,191 21,785 22,979
Total Preferred & Common Equity		 17,361 17,905 18,593 19,172 19,762 20,149 20,634 20,930 21,191 21,785 22,979
Total Common Equity		 17,361 17,905 18,593 19,172 19,762 20,149 20,634 20,930 21,191 21,785 22,979
Common Stock		 2,165 2,221 2,238 2,295 2,343 2,391 2,399 2,477 2,530 2,591 2,684
Retained Earnings		 15,526 15,933 16,771 17,254 17,774 18,303 18,528 18,862 19,423 19,960 20,878
Accumulated Other Comprehensive Income / (Loss)		 -330 -249 -416 -377 -355 -545 -293 -409 -762 -766 -583

Annual Metrics And Ratios for Stryker

This table displays calculated financial ratios and metrics derived from Stryker's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 2.80% 13.86% 9.88% 9.30% 9.43% -3.58% 19.21% 7.84% 11.11% 10.23% 11.16%
EBITDA Growth		 38.62% 15.71% 9.65% 13.83% 8.48% -17.19% 18.26% 12.53% 27.71% -3.38% 27.53%
EBIT Growth		 49.57% 10.72% 7.39% 14.20% 8.74% -23.73% 16.73% 17.62% 36.90% -4.93% 31.27%
NOPAT Growth		 179.02% 20.81% -39.10% 236.88% -42.35% -17.53% 24.17% 10.54% 34.18% -5.62% 11.19%
Net Income Growth		 179.42% 14.45% -38.07% 248.33% -41.37% -23.24% 24.70% 18.25% 34.22% -5.43% 8.45%
EPS Growth		 182.09% 15.08% -38.39% 248.51% -41.33% -23.36% 24.05% 18.43% 33.71% -5.94% 8.25%
Operating Cash Flow Growth		 -44.95% 95.21% -18.59% 67.42% -16.05% 49.57% -0.43% -19.58% 41.43% 14.31% 18.91%
Free Cash Flow Firm Growth		 -16.21% -517.93% 92.42% 255.89% 82.13% -561.85% 169.93% -147.42% 374.20% -23.25% -148.50%
Invested Capital Growth		 11.34% 54.44% 10.18% 23.96% 8.87% 23.38% 1.28% 13.90% 2.92% 4.23% 14.83%
Revenue Q/Q Growth		 0.98% 4.06% 2.59% 2.45% 2.30% 0.92% 2.63% 2.79% 3.08% 2.83% 3.01%
EBITDA Q/Q Growth		 8.28% 0.78% 3.01% 0.49% 9.80% -7.89% 3.19% 0.52% 10.90% -13.09% 41.00%
EBIT Q/Q Growth		 9.53% -1.23% 3.05% 0.34% 12.22% -11.94% 3.92% 0.15% 14.50% -16.66% 53.46%
NOPAT Q/Q Growth		 23.57% 1.54% -43.27% 184.69% -40.42% -4.93% 3.80% -4.34% 20.69% -15.46% 8.74%
Net Income Q/Q Growth		 22.26% -0.72% -42.66% 187.46% -39.20% -8.94% 4.95% -4.03% 22.44% -16.63% 10.30%
EPS Q/Q Growth		 23.13% -0.91% -42.74% 188.27% -39.25% -8.89% 4.83% -4.04% 22.40% -16.83% 10.38%
Operating Cash Flow Q/Q Growth		 8.16% -4.73% 1.37% 16.36% -12.43% 18.09% -6.77% 0.11% 16.48% 10.50% 4.39%
Free Cash Flow Firm Q/Q Growth		 22.11% -2.29% -216.62% -76.94% 489.19% -270.63% 163.13% 2.81% 39.08% 35.87% -8.21%
Invested Capital Q/Q Growth		 -1.74% -0.46% -3.53% 20.31% 4.23% 26.71% 0.70% 0.11% -0.36% -3.83% -2.38%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 66.38% 66.26% 65.73% 65.72% 65.14% 63.11% 64.11% 62.76% 63.70% 63.91% 63.96%
EBITDA Margin		 21.44% 21.78% 21.74% 22.64% 22.44% 19.27% 19.12% 19.95% 22.93% 20.10% 25.14%
Operating Margin		 18.71% 19.21% 18.46% 18.65% 18.23% 15.49% 15.10% 15.40% 18.97% 16.33% 19.47%
EBIT Margin		 17.44% 16.96% 16.58% 17.32% 17.21% 13.62% 13.33% 14.54% 17.92% 15.45% 20.39%
Profit (Net Income) Margin		 14.47% 14.54% 8.20% 26.12% 13.99% 11.14% 11.66% 12.78% 15.44% 13.25% 12.92%
Tax Burden Percent		 82.94% 85.74% 49.44% 150.81% 81.30% 81.83% 87.42% 87.89% 86.17% 85.71% 71.91%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 88.15%
Effective Tax Rate		 17.06% 14.26% 50.56% -50.81% 18.70% 18.17% 12.58% 12.11% 13.83% 14.29% 28.09%
Return on Invested Capital (ROIC)		 18.97% 17.10% 8.16% 23.42% 11.68% 8.27% 9.24% 9.49% 11.78% 10.74% 10.89%
ROIC Less NNEP Spread (ROIC-NNEP)		 44.00% 5.48% 5.37% 18.44% 9.83% 5.84% 6.71% 8.18% 10.07% 9.02% 8.38%
Return on Net Nonoperating Assets (RNNOA)		 -2.15% 1.14% 2.28% 9.31% 5.30% 4.08% 5.02% 5.48% 6.19% 4.52% 4.19%
Return on Equity (ROE)		 16.82% 18.24% 10.45% 32.73% 16.98% 12.35% 14.26% 14.97% 17.98% 15.26% 15.08%
Cash Return on Invested Capital (CROIC)		 8.24% -25.70% -1.53% 2.03% 3.19% -12.66% 7.96% -3.51% 8.90% 6.60% -2.92%
Operating Return on Assets (OROA)		 10.36% 10.48% 9.68% 9.53% 8.93% 6.06% 6.62% 7.50% 9.57% 8.43% 11.28%
Return on Assets (ROA)		 8.59% 8.99% 4.79% 14.38% 7.26% 4.96% 5.78% 6.59% 8.24% 7.22% 7.15%
Return on Common Equity (ROCE)		 16.82% 18.24% 10.44% 32.71% 16.98% 12.35% 14.26% 14.97% 17.98% 15.26% 15.08%
Return on Equity Simple (ROE_SIMPLE)		 16.91% 17.25% 10.23% 30.29% 16.26% 12.22% 13.40% 14.19% 17.02% 14.51% 0.00%
Net Operating Profit after Tax (NOPAT)		 1,544 1,865 1,136 3,826 2,206 1,819 2,259 2,497 3,350 3,162 3,516
NOPAT Margin		 15.52% 16.47% 9.13% 28.13% 14.82% 12.68% 13.20% 13.53% 16.34% 13.99% 14.00%
Net Nonoperating Expense Percent (NNEP)		 -25.03% 11.61% 2.79% 4.98% 1.86% 2.43% 2.53% 1.31% 1.71% 1.72% 2.51%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - 8.42% 10.61% 9.24% 9.18%
Cost of Revenue to Revenue		 33.62% 33.74% 34.27% 34.28% 34.86% 36.89% 35.89% 37.24% 36.30% 36.09% 36.04%
SG&A Expenses to Revenue		 36.30% 36.53% 36.58% 37.49% 35.99% 37.36% 37.57% 34.61% 34.69% 34.01% 34.44%
R&D to Revenue		 6.28% 6.31% 6.32% 6.34% 6.52% 6.86% 7.22% 7.88% 6.77% 6.49% 6.46%
Operating Expenses to Revenue		 47.67% 47.06% 47.28% 47.06% 46.92% 47.62% 49.01% 47.36% 44.74% 47.58% 44.50%
Earnings before Interest and Taxes (EBIT)		 1,735 1,921 2,063 2,356 2,562 1,954 2,281 2,683 3,673 3,492 5,121
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 2,132 2,467 2,705 3,079 3,340 2,766 3,271 3,681 4,701 4,542 6,314
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 3.72 4.32 5.41 4.71 5.84 6.78 6.59 5.46 6.06 6.65 6.00
Price to Tangible Book Value (P/TBV)		 12.26 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 357.44 0.00
Price to Revenue (P/Rev)		 3.18 3.64 4.33 4.06 5.02 6.18 5.73 4.92 5.50 6.07 5.35
Price to Earnings (P/E)		 21.98 25.03 52.85 15.54 35.89 55.45 49.20 38.47 35.62 45.86 41.41
Dividend Yield		 1.68% 1.42% 1.21% 1.31% 1.07% 1.00% 0.99% 1.18% 1.03% 0.90% 0.97%
Earnings Yield		 4.55% 4.00% 1.89% 6.44% 2.79% 1.80% 2.03% 2.60% 2.81% 2.18% 2.42%
Enterprise Value to Invested Capital (EV/IC)		 3.68 3.38 4.00 3.39 4.14 4.10 4.37 3.63 4.25 4.87 4.23
Enterprise Value to Revenue (EV/Rev)		 3.17 3.95 4.69 4.51 5.47 6.94 6.29 5.52 5.98 6.48 5.82
Enterprise Value to EBITDA (EV/EBITDA)		 14.80 18.14 21.57 19.93 24.38 36.02 32.89 27.66 26.09 32.22 23.15
Enterprise Value to EBIT (EV/EBIT)		 18.19 23.30 28.28 26.05 31.78 50.99 47.16 37.95 33.40 41.91 28.54
Enterprise Value to NOPAT (EV/NOPAT)		 20.44 24.00 51.38 16.04 36.91 54.77 47.62 40.78 36.61 46.29 41.58
Enterprise Value to Operating Cash Flow (EV/OCF)		 32.16 23.37 37.43 23.51 37.16 30.40 32.97 38.80 33.05 34.50 28.98
Enterprise Value to Free Cash Flow (EV/FCFF)		 47.06 0.00 0.00 185.43 135.07 0.00 55.25 0.00 48.46 75.33 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.47 0.72 0.72 0.84 0.87 1.07 0.84 0.79 0.70 0.66 0.71
Long-Term Debt to Equity		 0.38 0.70 0.66 0.72 0.80 1.01 0.84 0.71 0.59 0.59 0.66
Financial Leverage		 -0.05 0.21 0.42 0.50 0.54 0.70 0.75 0.67 0.61 0.50 0.50
Leverage Ratio		 1.96 2.03 2.18 2.28 2.34 2.49 2.47 2.27 2.18 2.11 2.11
Compound Leverage Factor		 1.96 2.03 2.18 2.28 2.34 2.49 2.47 2.27 2.18 2.11 1.86
Debt to Total Capital		 31.96% 41.99% 41.98% 45.67% 46.41% 51.68% 45.62% 43.99% 41.14% 39.72% 41.43%
Short-Term Debt to Total Capital		 6.14% 1.38% 3.67% 6.36% 3.59% 2.81% 0.03% 4.02% 6.63% 4.12% 2.61%
Long-Term Debt to Total Capital		 25.82% 40.61% 38.31% 39.31% 42.81% 48.86% 45.59% 39.97% 34.51% 35.61% 38.82%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.08% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 68.04% 58.01% 57.94% 54.33% 53.59% 48.33% 54.38% 56.01% 58.86% 60.28% 58.57%
Debt to EBITDA		 1.88 2.80 2.67 3.20 3.32 5.06 3.82 3.54 2.76 2.99 2.51
Net Debt to EBITDA		 -0.04 1.43 1.64 2.00 2.00 3.96 2.89 3.02 2.11 2.00 1.86
Long-Term Debt to EBITDA		 1.52 2.71 2.44 2.76 3.06 4.78 3.81 3.22 2.32 2.68 2.35
Debt to NOPAT		 2.59 3.71 6.36 2.58 5.03 7.69 5.52 5.23 3.88 4.30 4.51
Net Debt to NOPAT		 -0.05 1.89 3.90 1.61 3.02 6.03 4.19 4.45 2.97 2.88 3.34
Long-Term Debt to NOPAT		 2.09 3.59 5.80 2.22 4.64 7.27 5.52 4.75 3.25 3.85 4.23
Altman Z-Score		 4.43 4.02 4.33 3.69 4.17 3.78 4.43 4.12 4.72 5.29 4.82
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.07% 0.06% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.27 2.50 2.29 2.02 2.51 1.93 2.20 1.63 1.58 1.95 1.89
Quick Ratio		 1.64 1.70 1.43 1.25 1.66 1.14 1.33 0.87 0.86 1.11 1.04
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 671 -2,802 -212 331 603 -2,784 1,947 -923 2,531 1,943 -942
Operating Cash Flow to CapEx		 363.33% 390.82% 260.70% 456.29% 337.60% 672.90% 621.52% 446.26% 645.39% 561.85% 662.81%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -1.55
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 8.31
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 7.06
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.59 0.62 0.58 0.55 0.52 0.45 0.50 0.52 0.53 0.55 0.55
Accounts Receivable Turnover		 6.15 6.24 5.98 6.00 5.70 5.13 5.98 5.60 5.59 5.83 6.26
Inventory Turnover		 2.07 2.08 1.90 1.72 1.75 1.64 1.80 1.88 1.68 1.70 1.80
Fixed Asset Turnover		 8.66 8.18 7.02 6.38 6.13 5.40 6.13 6.36 6.63 6.78 6.86
Accounts Payable Turnover		 9.05 9.02 9.23 8.23 7.85 7.13 6.33 5.41 5.08 5.10 5.20
Days Sales Outstanding (DSO)		 59.34 58.48 61.08 60.78 64.07 71.14 61.05 65.16 65.26 62.61 58.32
Days Inventory Outstanding (DIO)		 176.11 175.24 192.39 212.13 208.78 223.18 202.36 194.13 216.79 215.22 203.33
Days Payable Outstanding (DPO)		 40.33 40.45 39.55 44.34 46.47 51.19 57.63 67.52 71.87 71.52 70.13
Cash Conversion Cycle (CCC)		 195.12 193.27 213.92 228.57 226.37 243.12 205.77 191.78 210.18 206.31 191.52
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 8,572 13,239 14,587 18,082 19,685 24,288 24,600 28,020 28,839 30,058 34,516
Invested Capital Turnover		 1.22 1.04 0.89 0.83 0.79 0.65 0.70 0.70 0.72 0.77 0.78
Increase / (Decrease) in Invested Capital		 873 4,667 1,348 3,495 1,603 4,603 312 3,420 819 1,219 4,458
Enterprise Value (EV)		 31,552 44,752 58,346 61,369 81,414 99,632 107,567 101,822 122,665 146,361 146,169
Market Capitalization		 31,633 41,222 53,903 55,209 74,749 88,665 98,107 90,702 112,723 137,257 134,410
Book Value per Share		 $22.66 $25.50 $26.63 $31.35 $34.21 $34.82 $39.44 $43.91 $48.94 $54.13 $58.63
Tangible Book Value per Share		 $6.87 ($0.84) ($1.81) ($2.66) ($1.31) ($13.97) ($7.64) ($8.32) ($3.27) $1.01 ($6.67)
Total Capital		 12,509 16,464 17,202 21,589 23,897 27,075 27,356 29,664 31,588 34,231 38,279
Total Debt		 3,998 6,914 7,222 9,859 11,090 13,991 12,479 13,048 12,995 13,597 15,859
Total Long-Term Debt		 3,230 6,686 6,590 8,486 10,231 13,230 12,472 11,857 10,901 12,188 14,859
Net Debt		 -81 3,530 4,429 6,160 6,665 10,967 9,460 11,120 9,942 9,104 11,759
Capital Expenditures (CapEx)		 270 490 598 572 649 487 525 588 575 755 761
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 1,130 1,557 2,347 2,600 3,092 2,403 2,456 3,235 3,638 4,147 3,861
Debt-free Net Working Capital (DFNWC)		 5,209 4,941 5,140 6,299 7,517 5,427 5,475 5,163 6,691 8,640 7,961
Net Working Capital (NWC)		 4,441 4,713 4,508 4,926 6,658 4,666 5,468 3,972 4,597 7,231 6,961
Net Nonoperating Expense (NNE)		 105 218 116 273 123 220 265 139 185 169 270
Net Nonoperating Obligations (NNO)		 61 3,689 4,607 6,352 6,878 11,204 9,723 11,404 10,246 9,424 12,096
Total Depreciation and Amortization (D&A)		 397 546 642 723 778 812 990 998 1,028 1,050 1,193
Debt-free, Cash-free Net Working Capital to Revenue		 11.36% 13.75% 18.86% 19.12% 20.77% 16.74% 14.36% 17.53% 17.75% 18.35% 15.37%
Debt-free Net Working Capital to Revenue		 52.37% 43.63% 41.31% 46.31% 50.50% 37.82% 32.00% 27.99% 32.64% 38.24% 31.70%
Net Working Capital to Revenue		 44.65% 41.62% 36.23% 36.22% 44.73% 32.51% 31.96% 21.53% 22.43% 32.00% 27.72%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $3.82 $4.40 $2.73 $9.50 $5.57 $4.26 $5.29 $6.23 $8.34 $7.86 $8.49
Adjusted Weighted Average Basic Shares Outstanding		 376.60M 374.10M 374M 374.10M 374M 375.50M 377M 378.20M 379.60M 381M 382.20M
Adjusted Diluted Earnings per Share		 $3.78 $4.35 $2.68 $9.34 $5.48 $4.20 $5.21 $6.17 $8.25 $7.76 $8.40
Adjusted Weighted Average Diluted Shares Outstanding		 380.90M 378.50M 380.10M 380.30M 379.90M 380.30M 382.30M 382.20M 383.70M 385.60M 386.50M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 372.98M 372.88M 374.64M 372.66M 374.58M 376.20M 377.54M 378.83M 380.26M 381.58M 382.69M
Normalized Net Operating Profit after Tax (NOPAT)		 1,544 1,865 1,608 1,776 2,206 1,819 2,259 2,734 3,381 3,999 3,638
Normalized NOPAT Margin		 15.52% 16.47% 12.92% 13.06% 14.82% 12.68% 13.20% 14.82% 16.50% 17.70% 14.48%
Pre Tax Income Margin		 17.44% 16.96% 16.58% 17.32% 17.21% 13.62% 13.33% 14.54% 17.92% 15.45% 17.97%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 8.44
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 5.79
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 7.18
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.54
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 36.21% 34.49% 72.06% 20.18% 37.35% 53.97% 47.64% 44.57% 35.99% 40.73% 39.56%
Augmented Payout Ratio		 84.85% 35.28% 94.61% 28.62% 52.09% 53.97% 47.64% 44.57% 35.99% 40.73% 39.56%

Quarterly Metrics And Ratios for Stryker

This table displays calculated financial ratios and metrics derived from Stryker's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - - - - - - - - - 383,360,762.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 383,360,762.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - 1.94
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 9.60% 11.78% 9.73% 8.53% 11.92% 10.68% 11.88% 11.07% 10.25% 11.42% 2.63%
EBITDA Growth		 6.10% 45.56% 26.39% 8.46% 15.92% -46.34% -12.43% 4.46% 2.06% 118.82% 10.66%
EBIT Growth		 6.50% 61.10% 35.94% 11.01% 20.02% -56.93% -17.23% 1.80% -1.34% 146.74% 10.77%
NOPAT Growth		 -8.25% 94.60% 29.49% 9.67% 17.02% -48.73% -13.66% 11.46% 9.21% 49.52% 14.50%
Net Income Growth		 -15.20% 103.02% 33.11% 11.79% 20.52% -52.23% -17.01% 7.15% 3.00% 55.49% 13.91%
EPS Growth		 -15.89% 102.72% 33.12% 10.88% 20.00% -52.68% -17.56% 7.01% 2.78% 56.03% 14.20%
Operating Cash Flow Growth		 18.11% 52.34% -54.16% -7.99% 40.38% 26.37% 22.55% 75.51% 4.48% 10.98% 132.40%
Free Cash Flow Firm Growth		 92.20% 112.52% -1,883.69% -166.92% -572.05% -275.17% -700.19% -1,139.34% -118.84% -475.82% 127.53%
Invested Capital Growth		 3.42% 2.92% 5.09% 4.18% 7.98% 4.23% 19.00% 17.46% 13.13% 14.83% -1.54%
Revenue Q/Q Growth		 -1.74% 18.46% -9.84% 3.41% 1.33% 17.15% -8.86% 2.66% 0.58% 18.39% -16.05%
EBITDA Q/Q Growth		 -2.33% 30.50% -19.85% 6.17% 4.38% -39.59% 30.81% 26.64% 1.98% 96.41% -50.61%
EBIT Q/Q Growth		 -3.34% 41.08% -24.71% 8.13% 4.51% -49.38% 44.70% 32.98% 1.28% 124.68% -56.83%
NOPAT Q/Q Growth		 -6.41% 58.07% -29.19% 4.70% -0.14% -30.75% 19.25% 35.16% -2.16% -5.19% -8.67%
Net Income Q/Q Growth		 -6.23% 65.17% -31.06% 4.70% 1.09% -34.53% 19.78% 35.17% -2.83% -1.16% -12.25%
EPS Q/Q Growth		 -6.74% 65.56% -31.21% 4.39% 0.93% -34.72% 19.86% 35.50% -3.06% -0.90% -12.27%
Operating Cash Flow Q/Q Growth		 52.62% 45.52% -86.65% 210.29% 132.86% 31.00% -87.05% 344.40% 38.61% 39.16% -72.89%
Free Cash Flow Firm Q/Q Growth		 -64.06% 264.42% -276.02% 43.79% -313.08% 57.14% -704.04% 12.93% 27.06% -12.77% 138.44%
Invested Capital Q/Q Growth		 -0.58% -0.36% 3.80% 1.33% 3.04% -3.83% 18.51% 0.02% -0.76% -2.38% 1.62%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 64.33% 63.68% 63.57% 63.00% 64.02% 64.85% 63.83% 63.78% 63.60% 64.54% 63.29%
EBITDA Margin		 23.04% 25.38% 22.56% 23.16% 23.86% 12.31% 17.66% 21.79% 22.09% 36.65% 21.56%
Operating Margin		 18.97% 21.62% 18.54% 19.38% 19.75% 9.03% 14.27% 18.48% 18.74% 25.16% 15.55%
EBIT Margin		 17.70% 21.08% 17.60% 18.41% 18.98% 8.20% 13.02% 16.87% 16.99% 32.24% 16.58%
Profit (Net Income) Margin		 14.10% 19.66% 15.03% 15.22% 15.18% 8.48% 11.15% 14.68% 14.18% 11.84% 12.38%
Tax Burden Percent		 79.63% 93.23% 85.37% 82.67% 79.96% 103.41% 85.60% 87.01% 83.48% 49.79% 87.65%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 73.75% 85.17%
Effective Tax Rate		 20.37% 6.77% 14.63% 17.33% 20.04% -3.41% 14.40% 12.99% 16.52% 50.21% 12.35%
Return on Invested Capital (ROIC)		 10.55% 14.53% 11.36% 11.53% 11.53% 7.16% 8.65% 11.61% 11.45% 9.74% 9.74%
ROIC Less NNEP Spread (ROIC-NNEP)		 10.11% 14.26% 10.98% 11.14% 11.23% 6.61% 8.16% 10.94% 10.73% 9.29% 9.18%
Return on Net Nonoperating Assets (RNNOA)		 6.64% 8.77% 6.81% 6.70% 6.53% 3.31% 5.18% 6.68% 6.32% 4.64% 5.60%
Return on Equity (ROE)		 17.19% 23.30% 18.17% 18.23% 18.06% 10.47% 13.83% 18.29% 17.77% 14.39% 15.34%
Cash Return on Invested Capital (CROIC)		 6.39% 8.90% 7.15% 8.07% 4.75% 6.60% -8.05% -6.51% -2.61% -2.92% 11.79%
Operating Return on Assets (OROA)		 9.51% 11.26% 9.68% 10.29% 10.19% 4.47% 7.08% 9.40% 9.11% 17.83% 9.08%
Return on Assets (ROA)		 7.57% 10.49% 8.27% 8.50% 8.15% 4.63% 6.06% 8.18% 7.61% 6.55% 6.78%
Return on Common Equity (ROCE)		 17.19% 23.30% 18.17% 18.23% 18.06% 10.47% 13.83% 18.29% 17.77% 14.39% 15.34%
Return on Equity Simple (ROE_SIMPLE)		 14.44% 0.00% 17.53% 17.45% 17.82% 0.00% 13.66% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 741 1,172 830 869 868 601 716 968 947 898 820
NOPAT Margin		 15.10% 20.15% 15.83% 16.02% 15.79% 9.34% 12.21% 16.08% 15.64% 12.53% 13.63%
Net Nonoperating Expense Percent (NNEP)		 0.44% 0.27% 0.37% 0.39% 0.30% 0.56% 0.49% 0.68% 0.72% 0.46% 0.56%
Return On Investment Capital (ROIC_SIMPLE)		 - 3.71% - - - 1.76% 1.90% 2.56% 2.47% 2.35% 2.18%
Cost of Revenue to Revenue		 35.67% 36.32% 36.43% 37.00% 35.98% 35.15% 36.17% 36.22% 36.40% 35.46% 36.71%
SG&A Expenses to Revenue		 34.83% 32.86% 35.09% 34.06% 34.51% 32.66% 39.21% 34.52% 33.76% 31.06% 37.89%
R&D to Revenue		 7.19% 6.02% 7.02% 6.69% 6.86% 5.56% 6.90% 6.76% 6.77% 5.59% 6.86%
Operating Expenses to Revenue		 45.37% 42.06% 45.03% 43.62% 44.27% 55.83% 49.56% 45.30% 44.86% 39.38% 47.74%
Earnings before Interest and Taxes (EBIT)		 869 1,226 923 998 1,043 528 764 1,016 1,029 2,312 998
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 1,131 1,476 1,183 1,256 1,311 792 1,036 1,312 1,338 2,628 1,298
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 5.74 6.06 7.07 6.56 6.83 6.65 6.79 7.13 6.49 6.00 5.47
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 357.44 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 5.17 5.50 6.47 6.06 6.27 6.07 6.12 6.35 5.80 5.35 4.98
Price to Earnings (P/E)		 39.77 35.62 40.36 37.59 38.35 45.86 49.68 51.81 48.02 41.41 37.68
Dividend Yield		 1.11% 1.03% 0.87% 0.93% 0.89% 0.90% 0.88% 0.84% 0.91% 0.97% 1.05%
Earnings Yield		 2.51% 2.81% 2.48% 2.66% 2.61% 2.18% 2.01% 1.93% 2.08% 2.42% 2.65%
Enterprise Value to Invested Capital (EV/IC)		 3.92 4.25 4.88 4.61 4.75 4.87 4.39 4.64 4.37 4.23 3.92
Enterprise Value to Revenue (EV/Rev)		 5.71 5.98 6.97 6.54 6.76 6.48 6.74 6.94 6.34 5.82 5.44
Enterprise Value to EBITDA (EV/EBITDA)		 26.79 26.09 29.53 27.72 28.41 32.22 35.59 37.14 34.52 23.15 21.36
Enterprise Value to EBIT (EV/EBIT)		 35.40 33.40 37.30 34.83 35.43 41.91 46.93 49.33 46.32 28.54 26.35
Enterprise Value to NOPAT (EV/NOPAT)		 40.90 36.61 41.27 38.69 39.70 46.29 51.31 52.50 47.81 41.58 38.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 35.64 33.05 42.10 40.96 38.67 34.50 36.48 34.69 31.99 28.98 25.58
Enterprise Value to Free Cash Flow (EV/FCFF)		 62.39 48.46 69.95 58.35 103.83 75.33 0.00 0.00 0.00 0.00 33.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.71 0.70 0.67 0.62 0.77 0.66 0.80 0.78 0.76 0.71 0.64
Long-Term Debt to Equity		 0.58 0.59 0.56 0.51 0.66 0.59 0.69 0.70 0.68 0.66 0.62
Financial Leverage		 0.66 0.61 0.62 0.60 0.58 0.50 0.63 0.61 0.59 0.50 0.61
Leverage Ratio		 2.15 2.18 2.11 2.06 2.15 2.11 2.13 2.09 2.17 2.11 2.10
Compound Leverage Factor		 2.15 2.18 2.11 2.06 2.15 2.11 2.13 2.09 2.17 1.56 1.79
Debt to Total Capital		 41.48% 41.14% 40.16% 38.21% 43.45% 39.72% 44.50% 43.90% 43.24% 41.43% 39.05%
Short-Term Debt to Total Capital		 7.54% 6.63% 6.42% 6.55% 6.06% 4.12% 6.36% 4.64% 4.56% 2.61% 1.32%
Long-Term Debt to Total Capital		 33.93% 34.51% 33.73% 31.66% 37.40% 35.61% 38.14% 39.26% 38.68% 38.82% 37.73%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 58.52% 58.86% 59.84% 61.79% 56.55% 60.28% 55.50% 56.10% 56.76% 58.57% 60.95%
Debt to EBITDA		 2.99 2.76 2.60 2.42 2.96 2.99 3.82 3.73 3.71 2.51 2.29
Net Debt to EBITDA		 2.54 2.11 2.11 2.03 2.07 2.00 3.27 3.17 2.96 1.86 1.83
Long-Term Debt to EBITDA		 2.45 2.32 2.18 2.01 2.55 2.68 3.27 3.33 3.32 2.35 2.21
Debt to NOPAT		 4.57 3.88 3.63 3.38 4.14 4.30 5.50 5.27 5.13 4.51 4.07
Net Debt to NOPAT		 3.87 2.97 2.95 2.84 2.89 2.88 4.71 4.48 4.10 3.34 3.25
Long-Term Debt to NOPAT		 3.74 3.25 3.05 2.80 3.56 3.85 4.72 4.71 4.59 4.23 3.93
Altman Z-Score		 4.36 4.51 5.40 5.43 4.84 5.06 4.67 4.93 4.70 4.63 4.67
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.48 1.58 1.71 1.68 1.91 1.95 1.64 1.78 1.85 1.89 2.11
Quick Ratio		 0.70 0.86 0.85 0.81 1.10 1.11 0.80 0.88 0.94 1.04 1.04
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -215 353 -621 -349 -1,442 -618 -4,971 -4,328 -3,157 -3,560 1,368
Operating Cash Flow to CapEx		 709.46% 1,053.79% 122.16% 416.45% 867.06% 725.94% 203.25% 607.10% 823.53% 799.63% 350.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 9.25
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.93
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.80
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.54 0.53 0.55 0.56 0.54 0.55 0.54 0.56 0.54 0.55 0.55
Accounts Receivable Turnover		 6.23 5.59 6.27 6.22 6.27 5.83 6.25 6.32 6.61 6.26 6.71
Inventory Turnover		 1.66 1.68 1.62 1.61 1.57 1.70 1.65 1.65 1.65 1.80 1.74
Fixed Asset Turnover		 6.74 6.63 6.66 6.68 6.73 6.78 6.83 6.79 6.81 6.86 6.81
Accounts Payable Turnover		 5.81 5.08 5.81 5.92 6.08 5.10 6.17 6.22 6.19 5.20 5.98
Days Sales Outstanding (DSO)		 58.55 65.26 58.22 58.73 58.24 62.61 58.43 57.77 55.23 58.32 54.40
Days Inventory Outstanding (DIO)		 219.33 216.79 225.09 226.09 231.97 215.22 220.98 220.76 221.87 203.33 210.16
Days Payable Outstanding (DPO)		 62.78 71.87 62.82 61.70 60.03 71.52 59.11 58.67 59.00 70.13 61.03
Cash Conversion Cycle (CCC)		 215.10 210.18 220.50 223.12 230.18 206.31 220.30 219.87 218.11 191.52 203.53
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 28,944 28,839 29,935 30,332 31,254 30,058 35,622 35,628 35,358 34,516 35,074
Invested Capital Turnover		 0.70 0.72 0.72 0.72 0.73 0.77 0.71 0.72 0.73 0.78 0.71
Increase / (Decrease) in Invested Capital		 956 819 1,451 1,218 2,310 1,219 5,687 5,296 4,104 4,458 -548
Enterprise Value (EV)		 113,551 122,665 146,092 139,883 148,467 146,361 156,415 165,312 154,580 146,169 137,506
Market Capitalization		 102,797 112,723 135,634 129,618 137,667 137,257 142,043 151,196 141,328 134,410 125,748
Book Value per Share		 $47.15 $48.94 $50.40 $51.88 $52.87 $54.13 $54.85 $55.45 $56.98 $58.63 $60.05
Tangible Book Value per Share		 ($5.17) ($3.27) ($1.81) ($0.02) ($3.11) $1.01 ($11.25) ($10.35) ($8.67) ($6.67) ($4.51)
Total Capital		 30,595 31,588 32,037 31,984 35,633 34,231 37,711 37,771 38,380 38,279 37,702
Total Debt		 12,690 12,995 12,865 12,222 15,484 13,597 16,781 16,580 16,595 15,859 14,723
Total Long-Term Debt		 10,382 10,901 10,807 10,127 13,325 12,188 14,383 14,829 14,845 14,859 14,224
Net Debt		 10,754 9,942 10,458 10,265 10,800 9,104 14,372 14,116 13,252 11,759 11,758
Capital Expenditures (CapEx)		 148 145 167 152 170 266 123 183 187 268 166
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 3,959 3,638 4,588 4,857 4,479 4,147 5,082 5,002 4,704 3,861 4,557
Debt-free Net Working Capital (DFNWC)		 5,895 6,691 6,995 6,814 9,163 8,640 7,491 7,466 8,047 7,961 7,522
Net Working Capital (NWC)		 3,587 4,597 4,937 4,719 7,004 7,231 5,093 5,715 6,297 6,961 7,023
Net Nonoperating Expense (NNE)		 49 29 42 44 34 55 62 84 88 49 75
Net Nonoperating Obligations (NNO)		 11,039 10,246 10,763 10,570 11,105 9,424 14,692 14,437 13,573 12,096 12,095
Total Depreciation and Amortization (D&A)		 262 250 260 258 268 264 272 296 309 316 300
Debt-free, Cash-free Net Working Capital to Revenue		 19.91% 17.75% 21.89% 22.71% 20.38% 18.35% 21.89% 21.00% 19.29% 15.37% 18.03%
Debt-free Net Working Capital to Revenue		 29.65% 32.64% 33.37% 31.86% 41.70% 38.24% 32.26% 31.35% 33.01% 31.70% 29.77%
Net Working Capital to Revenue		 18.04% 22.43% 23.55% 22.06% 31.87% 32.00% 21.94% 23.99% 25.83% 27.72% 27.79%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $1.82 $3.01 $2.07 $2.17 $2.18 $1.44 $1.71 $2.32 $2.25 $2.21 $1.95
Adjusted Weighted Average Basic Shares Outstanding		 379.80M 379.60M 380.40M 381M 381.10M 381M 381.70M 382.20M 382.40M 382.20M 382.90M
Adjusted Diluted Earnings per Share		 $1.80 $2.98 $2.05 $2.14 $2.16 $1.41 $1.69 $2.29 $2.22 $2.20 $1.93
Adjusted Weighted Average Diluted Shares Outstanding		 384M 383.70M 385.10M 385.40M 385.60M 385.60M 386.40M 386.40M 386.70M 386.50M 386.50M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 379.89M 380.26M 380.95M 381.08M 381.22M 381.58M 382.16M 382.31M 382.42M 382.69M 383.36M
Normalized Net Operating Profit after Tax (NOPAT)		 741 1,172 830 869 868 407 746 1,016 1,008 1,268 820
Normalized NOPAT Margin		 15.10% 20.15% 15.83% 16.02% 15.79% 6.32% 12.73% 16.88% 16.65% 17.68% 13.63%
Pre Tax Income Margin		 17.70% 21.08% 17.60% 18.41% 18.98% 8.20% 13.02% 16.87% 16.99% 23.78% 14.12%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 6.74
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 5.54
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 5.62
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.42
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 43.21% 35.99% 34.48% 34.19% 33.40% 40.73% 43.20% 42.87% 43.09% 39.56% 38.99%
Augmented Payout Ratio		 43.21% 35.99% 34.48% 34.19% 33.40% 40.73% 43.20% 42.87% 43.09% 39.56% 38.99%

Financials Breakdown Chart

Key Financial Trends

Here are the key trends for Stryker (SYK) based on quarterly statements from the last four years. The focus is on cash flow, income statement, and balance sheet data to highlight where the company has strengthened or faced headwinds.

  • Revenue growth with margin expansion: Q4 2025 Operating Revenue was 7,171,000,000 USD, up from 6,436,000,000 USD in Q4 2024. Total Gross Profit in Q4 2025 was 4,628,000,000 USD, yielding a gross margin of about 64.5% versus roughly 57.6% in Q4 2024, indicating both higher sales and improving efficiency.
  • Strong operating profitability in latest quarter: Q4 2025 Total Operating Income reached 1,804,000,000 USD, for an operating margin near 25.2% (1,804,000,000 / 7,171,000,000).
  • Healthy quarterly net income and EPS: Q4 2025 Net Income (continuing operations) was 849,000,000 USD. Basic EPS was 2.21 USD and Diluted EPS was 2.20 USD, signaling solid earnings per share growth versus prior periods.
  • Robust operating cash flow supports liquidity: Q4 2025 Net Cash From Continuing Operating Activities was 2,143,000,000 USD, underscoring strong cash generation from core operations.
  • Solid balance-sheet posture and liquidity: As of Q3 2025, Total Assets were 47.057B USD, Total Liabilities 25.272B USD, and Total Equity 21.785B USD. Cash & Equivalents stood at about 3.256B USD; Total Current Assets were around 13.71B USD, and Total Current Liabilities roughly 7.414B USD, indicating ample liquidity and a comfortable current ratio.
  • Steady shareholder returns via dividends: The company consistently paid 0.84 USD per share in cash dividends across Q1–Q4 2025, reflecting a stable payout policy that supports income-focused investors.
  • Continued investment in R&D: R&D expense runs around 400–410 million USD per quarter (e.g., Q4 2025 RD 401M, Q3 2025 RD 410M, Q2 2025 RD 407M, Q1 2025 RD 405M), signaling ongoing product development and potential for durable revenue growth.
  • Capex discipline with growth tilt: Purchase of Property, Plant & Equipment has been in the 180–270 million USD range per quarter (e.g., Q4 2025 PPE -268M; Q3 2025 PPE -187M; Q2 2025 PPE -183M; Q1 2025 PPE -123M), indicating targeted investment in capacity and efficiency improvements while cash flow remains strong.
  • Tax rate variability across quarters: In some quarters (notably Q4 2025) the reported tax expense yields a higher effective tax rate relative to other periods, suggesting timing effects or one-off items that can swing quarterly results. Other quarters show more typical rates.
  • Debt burden and financing pressure: Long-term debt hovered in the mid-teens of billions (around 14.8–14.9B USD in recent balance sheets). Net cash from financing activities was negative in several periods (reflecting debt repayments and dividend outlays), which could constrain cash flexibility in downturns or during aggressive capital allocation.\n
05/14/26 08:09 AM ETAI Generated. May Contain Errors.

Stryker Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Stryker's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Stryker's net income appears to be on an upward trend, with a most recent value of $3.25 billion in 2025, rising from $1.44 billion in 2015. The previous period was $2.99 billion in 2024. Check out Stryker's forecast to explore projected trends and price targets.

Stryker's total operating income in 2025 was $4.89 billion, based on the following breakdown:
  • Total Gross Profit: $16.07 billion
  • Total Operating Expenses: $11.18 billion

Over the last 10 years, Stryker's total revenue changed from $9.95 billion in 2015 to $25.12 billion in 2025, a change of 152.5%.

Stryker's total liabilities were at $25.42 billion at the end of 2025, a 13.8% increase from 2024, and a 229.7% increase since 2015.

In the past 10 years, Stryker's cash and equivalents has ranged from $1.84 billion in 2022 to $4.34 billion in 2019, and is currently $4.01 billion as of their latest financial filing in 2025.

Over the last 10 years, Stryker's book value per share changed from 22.66 in 2015 to 58.63 in 2025, a change of 158.7%.


Related Companies

Financial statements for NYSE:SYK last updated on 5/13/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Is this AI lab Elon’s SpaceX lifeline?
Elon Musk went from calling one AI lab 'evil' to striking a deal giving it access to SpaceX's entire Colossus ...
Chaikin Analytics | Sponsoredtc pixel
Collect $1,170 a month from silver
I've Rarely Seen This With Silver This combination - 20% dividends + 68% share appreciation - never happens...
Investors Alley | Sponsoredtc pixel
Elon’s Biggest Launch Ever: 15x Bigger Than SpaceX
The Man Who Called Nvidia Before It Soared 1,000% Issues New Elon Musk BUY Alert Luke Lango was ranked Amer...
InvestorPlace | Sponsoredtc pixel
This is the worst news for stocks in 50 years
Goldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...
TradeSmith | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
Millionaire trader: “Buy this before May 15.”
Hedge fund legend Larry Benedict - who beat the S&P 500 by 18 times in 2025 and generated $95 million for clie...
Brownstone Research | Sponsoredtc pixel
The system holding the dollar together is gone…
Saudi Arabia has terminated its 1974 petrodollar agreement with the United States - the deal that forced every...
Golden Portfolio | Sponsoredtc pixel
Elon’s ‘iPhone’ Could 10x Apple’s iPhone
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel